{
  "main_header": {
    "sid": 1239447,
    "name": "First Wave Biopharma, Inc.",
    "stock_name": "First Wave Biopharma, Inc.",
    "full_name": "First Wave Biopharma, Inc.",
    "name_url": "stocks-analysis/first-wave-biopharma-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.56",
    "chg": 0.29,
    "chgp": "12.78%",
    "dir": 1,
    "prev_price": "2.27",
    "mcapval": "4.18",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US33749P4081",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "172.43 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/first-wave-biopharma-inc-1239447-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is First Wave Biopharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-first-wave-biopharma-inc-technically-bullish-or-bearish-3547477",
        "imagepath": "",
        "date": "2025-09-20 19:56:07",
        "description": "As of 11 September 2025, the technical trend for First Wave Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view, particularly in the weekly MACD, Bollinger Bands, KST, and OBV, all of which are bullish. The daily moving averages also confirm a bullish trend. However, the monthly RSI indicates bearishness, which suggests some caution. \n\nIn terms of performance, the stock has shown impressive returns, with a 1-year return of 350.98% compared to the S&P 500's 17.14%, and a year-to-date return of 146.52% against the S&P 500's 12.22%. Overall, the technical indicators point to a bullish outlook, albeit with some mixed signals in the monthly timeframe...."
      },
      {
        "title": "First Wave Biopharma Hits New 52-Week High at $5.20",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/first-wave-biopharma-hits-new-52-week-high-at-520-3531534",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/FirstWaveBiopha_priceRelatedfactors_3531534.png",
        "date": "2025-09-18 13:22:40",
        "description": "First Wave Biopharma, Inc. achieved a new 52-week high of USD 5.20 on September 17, 2025, marking a 102.11% increase over the past year. The company operates in the Pharmaceuticals & Biotechnology sector, with a market cap of USD 4 million and notable financial challenges reflected in its metrics."
      },
      {
        "title": "First Wave Biopharma Hits New 52-Week High of $4.61",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/first-wave-biopharma-hits-new-52-week-high-of-461-3525932",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/FirstWaveBiopha_priceRelatedfactors_3525932.png",
        "date": "2025-09-17 15:20:12",
        "description": "First Wave Biopharma, Inc. achieved a new 52-week high of USD 4.61 on September 16, 2025, significantly up from its low of USD 0.93. The company, with a market cap of USD 4 million, has a low debt-to-equity ratio but is currently operating at a loss."
      },
      {
        "title": "First Wave Biopharma Hits New 52-Week High of $3.67",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/first-wave-biopharma-hits-new-52-week-high-of-367-3519634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/FirstWaveBiopha_priceRelatedfactors_3519634.png",
        "date": "2025-09-16 11:30:30",
        "description": "First Wave Biopharma, Inc. achieved a new 52-week high of USD 3.67 on September 15, 2025, marking a significant performance increase over the past year. The company, with a market capitalization of USD 4 million, operates in the Pharmaceuticals & Biotechnology sector and maintains a low debt-to-equity ratio."
      }
    ],
    "total": 9,
    "sid": "1239447",
    "stock_news_url": "https://www.marketsmojo.com/news/first-wave-biopharma-inc-1239447"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is First Wave Biopharma, Inc. technically bullish or bearish?

2025-09-20 19:56:07

As of 11 September 2025, the technical trend for First Wave Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view, particularly in the weekly MACD, Bollinger Bands, KST, and OBV, all of which are bullish. The daily moving averages also confirm a bullish trend. However, the monthly RSI indicates bearishness, which suggests some caution. In terms of performance, the stock has shown impressive returns, with a 1-year return of 350.98% compared to the S&P 500's 17.14%, and a year-to-date return of 146.52% against the S&P 500's 12.22%. Overall, the technical indicators point to a bullish outlook, albeit with some mixed signals in the monthly timeframe....

Read More

First Wave Biopharma Hits New 52-Week High at $5.20

2025-09-18 13:22:40

First Wave Biopharma, Inc. achieved a new 52-week high of USD 5.20 on September 17, 2025, marking a 102.11% increase over the past year. The company operates in the Pharmaceuticals & Biotechnology sector, with a market cap of USD 4 million and notable financial challenges reflected in its metrics.

Read More

First Wave Biopharma Hits New 52-Week High of $4.61

2025-09-17 15:20:12

First Wave Biopharma, Inc. achieved a new 52-week high of USD 4.61 on September 16, 2025, significantly up from its low of USD 0.93. The company, with a market cap of USD 4 million, has a low debt-to-equity ratio but is currently operating at a loss.

Read More

First Wave Biopharma Hits New 52-Week High of $3.67

2025-09-16 11:30:30

First Wave Biopharma, Inc. achieved a new 52-week high of USD 3.67 on September 15, 2025, marking a significant performance increase over the past year. The company, with a market capitalization of USD 4 million, operates in the Pharmaceuticals & Biotechnology sector and maintains a low debt-to-equity ratio.

Read More

View All News